Eurofins Laboratories found VBreathe capable of reducing a strand of coronavirus with 99.9% efficiency. This strand of coronavirus is accepted by the TGA (Therapeutic Goods Administration) as a surrogate for COVID-19.
Reduction in the following Bacteria:
Staphylococcus aureus - 99.9%
Escherichia coli - 99.9999%
Pseudomonas aeruginosa - 90%
Enterococcus hirae - 99.999%
88% reduction in the mould count within 24 hours and after 3 days there was a 95% reduction.
As per ISO 10993-5:2009 standards, the VBreathe Tasman’s controlled aerosolised droplets (vapours) are not toxic and do not adversely affect nasal and lung epithelial cells.
In 60 minutes, concentration of 1 Micron and 2.5 Micron particles were reduced by 97% and 96% respectively.
The VBreathe Tasman is Certified safe to be used in food areas.